C1q receptors

Clinical and Experimental Immunology

Volumn 120, Issue 3, 2000, Pages 406-412

  Eggleton, P ^a   Tenner, A J ^b   Reid, K B M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1Q; COMPLEMENT RECEPTOR;

AMINO ACID SEQUENCE; COMPLEMENT ACTIVATION; HUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; RECEPTOR AFFINITY; REVIEW;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD44; CALCIUM-BINDING PROTEINS; CALRETICULIN; CARRIER PROTEINS; COMPLEMENT C1Q; COMPLEMENT PATHWAY, CLASSICAL; HUMANS; MEMBRANE GLYCOPROTEINS; MITOCHONDRIAL PROTEINS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; RECEPTORS, COMPLEMENT; RECEPTORS, COMPLEMENT 3B; RIBONUCLEOPROTEINS;

EID: 0034121697     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2000.01218.x     Document Type: Review

References (62)

1. 1 Sobel AT, Bokish VA. Receptors for C4b and C1q on human peripheral lymphocytes and lymphoblastoid cells. Amsterdam: North Holland Publishing Co, 1975.
2. 2 Cooper NR. The classical complement pathway: activation and regulation of the first complement component. Adv Immunol 1985; 37:151-216.
3. 3 Jiang H, Burdick D, Glabe CG et al. beta-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain. J Immunol 1994; 152:5050-9.
4. 4 Kishore U, Leigh LEA, Eggleton P et al. Functional characterization of a recombinant form of the C-terminal globular head region of the B-chain of human serum complement protein, C1q. Biochem J 1998; 332:27-32.
5. 5 Shapiro L, Scherer PE. The crystal structure of a complement-1q family protein suggests evolutionary link to tumor necrosis factor. Curr Biol 1998; 8:335-8.
6. 6 Eggleton P, Reid KB, Tenner AJ. C1q - how many functions? How many receptors? Trends Cell Biol 1998; 8:428-31.
7. 7 Nepomuceno RR, Menschen Edman AH, Burgess WH et al. cDNA cloning and primary structure analysis of C1qR (P), the human C1q/ MBL/SPA receptor that mediates enhanced phagocytosis in vitro. Immunity 1997; 6:119-29.
8. 8 Nepomuceno RR, Ruiz S, Park M et al. C1qRP is a heavily O-glycosylated cell surface protein involved in the regulation of phagocytic activity. J Immunol 1999; 162:3583-9.
9. 9 Thiel S, Vorup Jensen T, Stover CM et al. A second serine protease associated with mannan-binding lectin that activates complement. Nature 1997; 386:506-10.
10. 10 Rees DJG, Jones IM, Handford PA et al. The role of B-hydroxyaspartate and adjacent carboxylate residues in the first EGF domain of human factor IX. EMBO J 1988; 7:2053-61.
11. 11 Wu YS, Bevilacqua VL, Berg JM. Fibrillin domain folding and calcium binding: significance to Marfan syndrome. Chem Biol 1995; 2:91-97.
12. 12 Ezekowitz RAB, Sastry K, Bailly P et al. Molecular characterization of the human macrophage mannose receptor: demonstration of multiple carbohydrate recognition-like domains and phagocytosis of yeast in cos-1 cells. J Exp Med 1990; 172:1785-94.
13. 13 Bobak DA, Gaither TG, Frank MM et al. Modulation of FcR function by complement: subcomponent C1q enhances the phagocytosis of IgG-opsonized targets by human monocytes and culture derived macrophages. J Immunol 1987; 138:1150-6.
14. 14 Guan E, Robinson SL, Goodman EB et al. Cell-surface protein identified on phagocytic cells modulates the C1q-mediated enhancement of phagocytosis. J Immunol 1994; 152:4005-16.
15. 15 Hess KL, Tudor KSRS, Johnson JD et al. Human and murine high endothelial venule cells phagocytose apoptotic leukocytes. Exp Cell Res 1997; 236:404-11.
16. 16 Walport MJ, Davies KA, Botto M. C1q and systemic erythematosus. Immunobiology 1998; 199:265-85.
17. 17 Botto M, Dell'agnola C, Bygrave AE et al. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 1998; 19:56-59.
18. 18 Petrenko O, Beavis A, Klaine M et al. The molecular characterization of the fetal stem cell marker AA4. Immunity 1999; 10:691-700.
19. 19 Goodman EB, Tenner AJ. Signal transduction mechanisms of C1q-mediated superoxide production: evidence for the involvement of temporally distinct staurosporine insensitive and sensitive pathways. J Immunol 1992; 148:3920-8.
20. 20 Goodman EB, Anderson DC, Tenner AJ. C1q triggers neutrophil superoxide production by a unique CD18-dependent mechanism. J Leuk Biol 1995; 58:168-76.
21. 21 Schur PH. Complement and lupus erythematosus. Arthritis Rheum 1982; 25:793-8.
22. 22 Belmont HM, Hopkins P, Edelson HS. Complement activity during systemic lupus erythematosus. Arthritis Rheum 1986; 29:1085-9.
23. 23 Ruiz S, Henschen Edman AH, Tenner AJ. Localization of the site on the complement component C1q required for the stimulation of neutrophil superoxide production. J Biol Chem 1995; 270:30627-34.
24. 24 Ruiz S, Henschen-Edman AH, Nagase H et al. Digestion of C1q collagen-like domain with matrix metalloproteinases, MMP-1, 2, 3 and 9, further defines the sequence involved in the stimulation of neutrophil superoxide production. J Leuk Biol 1999; 66:416-22.
25. 25 Krainer AR, Conway GC, Kozak D. Purification and characterization of pre-mRNA splicing factor SF2 from HeLa cells. Genes Dev 1990; 4:1158-71.
26. 26 Krainer AR, Mayeda A, Kozak D et al. Functional expression of cloned human splicing factor SF2: homology to RNA-binding proteins, U1 70K, and Drosophila sequencing regulators. Cell 1991; 66:383-94.
27. 27 Ghebrehiwet B, Lim BL, Peerschke EI et al. Isolation, cDNA cloning, and overexpression of a 33-kD cell surface glycoprotein that binds to the globular 'heads' of C1q. J Exp Med 1994; 179:1809-21.
28. 28 Narayanan AS, Lurton J, Raghu G. Distribution of receptors of collagen and globular domains of C1q in human lung fibroblasts. Am J Respir Cell Mol Biol 1997; 17:84-90.
29. 29 Eggleton P, Ghebrehiwet B, Sastry KN et al. Identification of a gC1q-binding protein (gC1q-R) on the surface of human neutrophils. Subcellular localization and binding properties in comparison with the cC1q-R. J Clin Invest 1995; 95:1569-78.
30. 30 Herwald H, Dedio J, Kellner R et al. Isolation and characterization of the kininogen-binding protein p33 from endothelial cells. Identity with the gC1q receptor. J Biol Chem 1996; 271:13040-7.
31. 31 Peerschke EI, Reid KB, Ghebrehiwet B. Identification of a novel 33-kDa C1q-binding site on human blood platelets. J Immunol 1994; 152:5896-901.
32. 32 van den Berg RH, Prins F, Faber Krol MC et al. Intracellular localization of the human receptor for the globular domains of C1q. J Immunol 1997; 158:3909-16.
33. 33 Dedio J, Jahnen-Dechent W, Bachmaan M et al. The multiligand-binding protein of C1qR, putative C1q receptor, is a mitochondrial protein. J Immunol 1998; 160:3534-42.
34. 34 Peterson KL, Zhang W, Lu PD et al. The C1q-binding cell membrane proteins cC1q-R and gC1q-R are released from activated cells: subcellular distribution and immunochemical characterization. Clin Immunol Immunopathol 1997; 84:17-26.
35. 35 Kuna P, Iyer M, Peerschke EI et al. Human C1q induces eosinophil migration. Clin Immunol Immunopathol 1996; 81:48-54.
36. 36 Ghebrehiwet B, Kew RR, Gruber BL et al. Murine mast cells express two types of C1q receptors that are involved in the induction of chemotaxis and chemokinesis. J Immunol 1995; 155:2614-9.
37. 37 Leigh LEA, Ghebrehiwet B, Perara TPS et al. C1q-mediated chemotaxis by human neutrophils: involvement of gC1qR and G-protein signalling mechanisms. Biochem J 1998; 330:247-54.
38. 38 Lim BL, Reid KB, Ghebrehiwet B et al. The binding protein for globular heads of complement C1q, gC1qR. Functional expression and characterization as a novel vitronectin binding factor. J Biol Chem 1996; 271:26739-44.
39. 39 Joseph K, Ghebrehiwet B, Peerschke EI et al. Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII: identity with the receptor that binds to the globular 'heads' of C1q (gC1q-R). Proc Natl Acad Sci USA 1996; 93:8552-7.
40. 40 Ghebrehiwet B, Silvestri L, McDevitt C. Identification of the Raji cell membrane-derived C1q inhibitor as a receptor for human C1q. Purification and immunochemical characterization. J Exp Med 1984; 160:1375-89.
41. 41 Erdei A, Reid KBM. C1q-binding material released from the membranes of Raji and U937 cells by limited proteolysis with trypsin. Biochem J 1988; 255:493-9.
42. 42 Malhotra R, Sim RB. Chemical and hydrodynamic characterization of the human leucocyte receptor for complement subcomponent C1q. Biochem J 1989; 262:625-31.
43. 43 Ghebrehiwet B. Functions associated with the C1q receptor. Behring Inst Mitt 1989; 84:204-15.
44. 44 Tino MJ, Wright JR. Surfactant protein A stimulates phagocytosis of specific pulmonary pathogens by alveolar macrophages. Am J Physiol 1996; 270:L677-88.
45. 45 Tenner AJ, Robinson SL, Ezekowitz RA. Mannose binding protein (MBP) enhances mononuclear phagocyte function via a receptor that contains the 126,000 M(r) component of the C1q receptor. Immunity 1995; 3:485-93.
46. 46 Malhotra R. Collectin receptor (C1q receptor): structure and function. Behring Inst Mitt 1993; 93:254-61.
47. 47 Peterson JR, Ora A, Van PN et al. Transient, lectin-like association of calreticulin with folding intermediates of cellular and viral glycoproteins. Mol Biol Cell 1995; 6:1173-84.
48. 48 McCauliffe DP, Zappi E, Lieu TS et al. A human Ro/SS-A autoantigen is the homologue of calreticulin and is highly homologous with onchocercal RAL-1 antigen and an aplysia 'memory molecule'. J Clin Invest 1990; 86:332-5.
49. 49 Rokeach LA, Haselby JA, Meilof JF et al. Characterization of the autoantigen calreticulin. J Immunol 1991; 147:3031-9.
50. 50 Lieu TS, Sontheimer RD. A subpopulation of WIL-2 cell calreticulin molecules is associated with RO/SS-A ribonucleoprotein particles. Lupus 1997; 6:40-47.
51. 51 Malhotra R, Willis AC, Jensenius JC et al. Structure and homology of human C1q receptor (collectin receptor). Immunology 1993; 78:341-8.
52. 52 Stuart GR, Lynch NJ, Lu J et al. Localisation of the C1q binding site within C1q receptor/calreticulin. FEBS Letters 1996; 397:245-9.
53. 53 Eggleton P, Lieu TS, Zappi EG et al. Calreticulin is released from activated neutrophils and binds to C1q and mannan-binding protein. Clin Immunol Immunopathol 1994; 72:405-9.
54. 54 Eggleton P, Ghebrehiwet B, Coburn JP et al. Characterization of the human neutrophil C1q receptor and functional effects of free ligand on activated neutrophils. Blood 1994; 84:1640-9.
55. 55 Eggleton P, Reid KB, Kishore U et al. Clinical relevance of calreticulin in systemic lupus erythematosus. Lupus 1997; 6:564-71.
56. 56 Kishore U, Sontheimer RD, Sastry KN et al. The systemic lupus erythematosus (SLE) disease autoantigen-calreticulin can inhibit C1q association with immune complexes. Clin Exp Immunol 1997; 108:181-90.
57. 57 Kishore U, Sontheimer RD, Sastry KN et al. Release of calreticulin from neutrophils may alter C1q-mediated immune functions. Biochem J 1997; 322:543-50.
58. 58 Kovacs H, Campbell ID, Strong P et al. CH2-like IgG motifs localized in the autoantigen-calreticulin hind to C1q and can inhibit IgG mediated complement activation. Biochemistry 1998; 37:17865-74.
59. 59 Duncan AR, Winter G. Localization of the binding site for the human high-affinity Fc receptor on IgG. Nature 1988; 332:738-40.
60. 60 Medof ME, Oger JJF. Competition for immune complexes by red cells in human blood. J Lab Clin Immunol 1982; 7:7-13.
61. 61 Cornacoff JB, Herbert LA, Smead WL et al. Primate erythrocyte immune-complex clearing mechanisms. J Clin Invest 1983; 71:236-47.
62. 62 Klickstein LB, Barbashov SF, Liu T et al. Complement receptor type 1 (CR1, CD35) is a receptor for C1q. Immunity 1997; 7: 345-55.